Steady Growth Amidst Headwinds
HDFC Life Insurance's Q3FY26 results revealed 11% year-on-year growth in annualised premium equivalent (APE) to ₹3,970 crore. This performance, largely in line with industry trends and analyst expectations, has reassured brokerages about the insurer's durable growth prospects.
The company saw modest growth in its value of new business (VNB), though margins experienced a sequential dip but remained within guided ranges. Brokerages like Emkay Global, Elara Capital, and Motilal Oswal view the quarter as operationally steady, indicating sustained underlying business momentum.
Margin Pressure and Expected Recovery
Margins were a key point of discussion, with the VNB margin declining to approximately 24% in Q3 from over 26% a year earlier. This dip is largely attributed to GST input tax credit losses and increased expenses from investments in branch expansion and manpower. Elara Capital termed the margin performance 'soft,' also noting persistency-related operating variances.
However, analysts believe the worst of the GST impact is likely past. Management has reduced the estimated annualised GST impact, and further narrowing is expected in Q4 due to operating leverage, a favorable product mix, and a higher proportion of protection business.
Strategic Channel Mix and Valuations
Growth in the bancassurance channel remained muted amid rising competition and pricing pressures. HDFC Life Insurance stated its wallet share within HDFC Bank remains stable. The company has consciously avoided aggressive pricing in multi-insurer bancassurance, prioritizing margin protection over immediate volume growth.
Concurrently, investments in proprietary channels are accelerating. The agency channel posted double-digit growth, adding significant agents and expanding its branch network. Brokerages anticipate this deeper reach will diversify growth and offset near-term softness in bancassurance.
On valuations, brokerages remain constructive, with several maintaining 'Buy' ratings and offering target prices ranging up to ₹930. The consensus is that HDFC Life Insurance is well-positioned for steady growth and value compounding, with acceleration remaining the key trigger for a stock rerating.